Costs of Intensive Psychiatric Care for Treatment-resistant Minors

被引:0
|
作者
Paakkonen, Tarja [1 ,2 ]
Tiihonen, Jari [2 ]
Paakkonen, Heikki [3 ]
Hallikainen, Tero [2 ]
Ryynanen, Olli-Pekka [4 ]
Kinnunen, Juha [1 ]
机构
[1] Univ Eastern Finland, Dept Social & Hlth Management, Kuopio, Finland
[2] Univ Eastern Finland, Dept Forens Psychiat, Kuopio, Finland
[3] Kuopio Univ Hosp, Prehosp Emergency Care Emergency & Intens Care, SF-70210 Kuopio, Finland
[4] Univ Eastern Finland, Dept Publ Hlth & Gen Practice, Kuopio, Finland
来源
关键词
SUBSTANCE USE; CHILDREN; DISORDERS; BEHAVIOR;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Mental health problems in childhood and adolescence result in high costs to society. Despite the relevance of these problems, there are still relatively few economic evaluations of this domain, in particular the evaluation of the costs of treatment-resistant minors. Aim of the Study: The study is aimed to evaluate the costs of mental services use of 52 treatment-resistant minors at the Intensive Psychiatric Care Unit of the Niuvanniemi Hospital, in Kupio, Finland, and the costs of the mental health services used by these patients before their referral to this unit. Methods: The data were collected from case history files of minors (N = 52) who were directed to the intensive psychiatric care unit between 2004 and 2007. The data included information of the use of earlier specialised medical psychiatric care. The study evaluated the cost of daily bed charges for treatment-resistant minors. Results: The mean duration of the intensive psychiatric care unit treatment was twelve months. The average cost was (sic) 367,150/patient. Fifty-one per cent of the minors were discharged to less intensive mental health services after the intensive psychiatric care. Conclusions: The costs of intensive psychiatric treatment are currently high. Benefits may be achieved over time. Further research should monitor and analyse the benefit of such expensive treatment on the outcomes of treatment-resistant patients over time, an investment in the minors' future, that ultimately benefits society.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 50 条
  • [21] Deep brain stimulation for treatment-resistant depression: A psychiatric perspective
    Giacobbe P.
    Kennedy S.H.
    Current Psychiatry Reports, 2006, 8 (6) : 437 - 444
  • [22] PSYCHIATRIC AND CARDIOMETABOLIC COMOR-BIDITIES OF TREATMENT-RESISTANT DEPRESSION
    Xiong, Ying
    Liu, Shengxin
    Thi Thuy Dung Nguyen
    Gong, Tong
    Kuja-Halkola, Ralf
    Lichtenstein, Paul
    Sullivan, Patrick
    Yi, Lu
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 : 125 - 126
  • [23] Treatment-resistant depression: An overview for psychiatric advanced practice nurses
    Kameg, Brayden N.
    Kameg, Kirstyn M.
    PERSPECTIVES IN PSYCHIATRIC CARE, 2021, 57 (02) : 689 - 694
  • [24] Private-payer Costs for Employees with Treatment-resistant Depression
    Kellar, Jamie
    von Heymann, Chris
    Zingaro, Joseph
    Kuriakose, Beena
    Li, Aileen
    Mittmann, Nicole
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (04) : E67 - +
  • [25] Treatment-resistant depression increases health costs and resource utilization
    Lepine, Beatrice Alinka
    Moreno, Ricardo Alberto
    Campos, Rodolfo Nunes
    Couttolenc, Bernard Francois
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2012, 34 (04) : 379 - 388
  • [26] LIABILITY FOR TREATMENT COSTS OF MINORS
    KOHLHAAS, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1969, 94 (18) : 975 - &
  • [27] Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression
    Lynch, Frances L.
    Dickerson, John F.
    O'Keeffe-Rosetti, Maureen
    Chow, Wing
    Pesa, Jacqueline
    JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (02)
  • [28] Inflammatory predictors of response to intensive inpatient treatment in severe treatment-resistant depression
    Strawbridge, R.
    Powell, T. R.
    Breen, G.
    Young, A. H.
    Cleare, A. J.
    BIPOLAR DISORDERS, 2016, 18 : 144 - 145
  • [29] The costs of nonbeneficial treatment in the intensive care setting
    Gilmer, T
    Schneiderman, LJ
    Teetzell, H
    Blustein, J
    Briggs, K
    Cohn, F
    Cranford, R
    Dugan, D
    Komatsu, G
    Young, E
    HEALTH AFFAIRS, 2005, 24 (04) : 961 - 971
  • [30] Treatment-Resistant Major Depression and the Capacity to Terminate Care
    Sommer, Barbara R.
    Roybal, Donna J.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S106 - S106